Coronary Stent (Drug-Eluting)

Interventional Devices

Coronary Stent (Drug-Eluting)(42 products)

Drug-eluting stents for coronary artery disease

Firehawk Rapamycin Target-Eluting Stent

NMPA, CE, FDA

Firehawk Rapamycin Target-Eluting Stent

MicroPort Scientific Corporation

The world's first target-eluting stent with unique ab-luminal drug coating technology, featuring micro-groove design for precise drug delivery. It has been implanted in over 1 million patients worldwide.

Targeted drug delivery with micro-groove technologyUltrathin strut thickness (60μm)Biocompatible polymer coatingExcellent deliverability and flexibility

Applications:

De novo coronary artery lesionsIn-stent restenosisSmall vessel diseaseBifurcation lesions

Firebird 2 Rapamycin-Eluting Stent

NMPA, CE

Firebird 2 Rapamycin-Eluting Stent

MicroPort Scientific Corporation

Second-generation drug-eluting stent with optimized polymer and drug release kinetics. One of the most widely used coronary stents in China with proven long-term clinical outcomes.

Proven long-term clinical data (10+ years)Optimized drug release profileLow thrombosis rateExcellent radial strength

Applications:

Standard coronary artery diseaseLong lesionsChronic total occlusionsAcute coronary syndromes

Partner Rapamycin-Eluting Stent

NMPA, CE

Partner Rapamycin-Eluting Stent

Lepu Medical Technology (Beijing) Co., Ltd.

One of China's first domestically developed drug-eluting stents. Features a biocompatible polymer coating with controlled drug release, providing reliable treatment for coronary artery disease.

Pioneer in Chinese DES technologyBiocompatible polymer coatingControlled rapamycin releaseProven 5-year clinical data

Applications:

De novo coronary lesionsRestenotic lesionsDiabetic patientsMulti-vessel disease

NeoVas Bioresorbable Scaffold

NMPA

NeoVas Bioresorbable Scaffold

Lepu Medical Technology (Beijing) Co., Ltd.

China's first approved bioresorbable vascular scaffold (BRS) made from PLLA (poly-L-lactic acid). Fully absorbed by the body within 3 years, leaving no permanent implant behind.

First approved BRS in ChinaPLLA-based fully bioresorbableDisappears within 3 yearsRestores natural vessel function

Applications:

Young patients with de novo lesionsVessels 2.5-3.75mm diameterShort to moderate length lesionsPatients preferring no permanent implant

EXCEL Bioabsorbable Polymer Stent

NMPA, CE

EXCEL Bioabsorbable Polymer Stent

JW Medical Systems Co., Ltd.

A drug-eluting stent featuring bioabsorbable polymer coating that completely degrades within 6-9 months, reducing long-term inflammatory response. One of the market leaders in China.

Bioabsorbable polymer (degrades in 6-9 months)Reduced late inflammatory responseExcellent biocompatibilityHigh radial strength

Applications:

Standard coronary interventionsHigh-risk patientsLong lesions requiring supportDiabetic coronary disease

BuMA Sirolimus-Eluting Stent

NMPA

BuMA Sirolimus-Eluting Stent

JW Medical Systems Co., Ltd.

A next-generation drug-eluting stent with biodegradable polymer and thin strut design. Features enhanced endothelialization and reduced thrombosis risk.

Biodegradable polymer coatingUltra-thin strut design (60μm)Rapid endothelializationLow late stent thrombosis

Applications:

Complex coronary lesionsBifurcation stentingSmall vessel diseasePatients at high thrombosis risk

IBS Iron-Based Bioresorbable Scaffold

CE, NMPA (pending)

IBS Iron-Based Bioresorbable Scaffold

Lifetech Scientific (Shenzhen) Co., Ltd.

The world's first iron-based bioresorbable coronary stent, offering superior mechanical strength compared to polymer-based BRS. Features controlled degradation timeline and excellent vessel support.

Iron-based bioresorbable materialSuperior radial strength vs polymer BRSThinner struts (60-80μm)Controlled degradation (12-24 months)

Applications:

De novo coronary lesionsYoung patientsVessels 2.5-4.0mm diameterPatients preferring temporary implant

XINSORB Bioresorbable Scaffold

NMPA

XINSORB Bioresorbable Scaffold

Lifetech Scientific (Shenzhen) Co., Ltd.

A PLLA-based bioresorbable vascular scaffold designed for coronary artery disease treatment. Features optimized scaffold design for improved deliverability and vessel support.

PLLA-based bioresorbable materialOptimized scaffold geometryGood deliverabilityControlled degradation profile

Applications:

De novo coronary lesionsVessels 2.5-3.5mm diameterShort to moderate length lesionsYoung active patients

BuMA Supreme Drug-Eluting Stent

NMPA

BuMA Supreme Drug-Eluting Stent

Beijing SINOMED Technologies, Inc.

A next-generation drug-eluting stent featuring a unique biodegradable polymer and ultra-thin strut design. Provides excellent vessel wall apposition and rapid endothelialization.

Biodegradable polymer coatingUltra-thin strut (60μm)Rapid endothelializationLow late lumen loss

Applications:

Complex coronary interventionsHigh-risk patientsLong lesionsDiabetic patients

NovoStent Sirolimus-Eluting Stent

NMPA

NovoStent Sirolimus-Eluting Stent

Beijing SINOMED Technologies, Inc.

A sirolimus-eluting coronary stent with biocompatible polymer coating. Designed for reliable drug delivery and excellent clinical outcomes in various coronary lesion types.

Sirolimus drug coatingBiocompatible polymerConsistent drug releaseGood radial strength

Applications:

Standard coronary artery diseaseBail-out stentingIn-stent restenosisAcute coronary syndromes

MedFavour Drug-Eluting Stent

NMPA

MedFavour Drug-Eluting Stent

Shanghai Yinyi Medical Technology Co., Ltd.

A drug-eluting coronary stent featuring biodegradable polymer coating with controlled drug release. Designed for optimal vessel healing and reduced late adverse events.

Biodegradable polymer coatingControlled drug releaseThin strut designGood flexibility

Applications:

De novo coronary lesionsSmall vessel diseaseLong lesionsHigh bleeding risk patients

MedFavour Plus Ultra-Thin Stent

NMPA

MedFavour Plus Ultra-Thin Stent

Shanghai Yinyi Medical Technology Co., Ltd.

Next-generation ultra-thin strut drug-eluting stent with enhanced deliverability and rapid endothelialization. Features optimized polymer degradation profile.

Ultra-thin strut (55μm)Rapid endothelializationEnhanced deliverabilityOptimized polymer degradation

Applications:

Complex coronary interventionsBifurcation lesionsSmall vessel diseasePatients requiring rapid healing

NOYA Drug-Eluting Stent

NMPA

NOYA Drug-Eluting Stent

Beijing Wanlifei Medical Technology Co., Ltd.

A bioresorbable polymer drug-eluting stent designed for coronary artery disease. Features controlled sirolimus release and excellent biocompatibility.

Bioresorbable polymer coatingControlled sirolimus releaseGood radial strengthThin strut design

Applications:

De novo coronary lesionsStandard coronary interventionsLong lesionsMulti-vessel disease

NOYA Plus Next-Gen Stent

NMPA

NOYA Plus Next-Gen Stent

Beijing Wanlifei Medical Technology Co., Ltd.

Next-generation drug-eluting stent with enhanced polymer technology and ultra-thin strut design. Improved deliverability and vessel wall apposition.

Enhanced polymer technologyUltra-thin strut (60μm)Improved deliverabilityRapid endothelialization

Applications:

Complex coronary lesionsHigh-risk patientsDiabetic patientsLong lesions requiring support

HuaStent Drug-Eluting Stent

NMPA

HuaStent Drug-Eluting Stent

Beijing Innovate Medical Technology Co., Ltd.

A sirolimus-eluting coronary stent with bioabsorbable polymer coating. Designed for reliable performance in various coronary lesion types with good long-term outcomes.

Bioabsorbable polymer coatingSirolimus drug releaseGood vessel wall appositionMultiple size options

Applications:

Standard coronary interventionsDe novo lesionsIn-stent restenosisBail-out stenting

HuaStent Plus Thin-Strut Stent

NMPA

HuaStent Plus Thin-Strut Stent

Beijing Innovate Medical Technology Co., Ltd.

Advanced thin-strut drug-eluting stent with enhanced biocompatibility and rapid endothelialization. Optimized for complex coronary interventions.

Ultra-thin strut designEnhanced biocompatibilityRapid endothelializationGood flexibility

Applications:

Complex coronary lesionsBifurcation stentingLong lesionsHigh-risk patients

BioHeart Drug-Eluting Stent

NMPA, CE

BioHeart Drug-Eluting Stent

Biosensors International Group, Ltd.

A drug-eluting coronary stent featuring biocompatible polymer coating with controlled drug release. Designed for excellent clinical outcomes in various coronary lesion types.

Biocompatible polymer coatingControlled drug releaseGood radial strengthThin strut design

Applications:

De novo coronary lesionsStandard coronary interventionsLong lesionsMulti-vessel disease

BioHeart Plus Ultra-Thin Stent

NMPA, CE

BioHeart Plus Ultra-Thin Stent

Biosensors International Group, Ltd.

Next-generation ultra-thin strut drug-eluting stent with enhanced deliverability and rapid endothelialization. Features optimized polymer degradation for improved vessel healing.

Ultra-thin strut (60μm)Rapid endothelializationEnhanced deliverabilityOptimized polymer degradation

Applications:

Complex coronary interventionsBifurcation lesionsSmall vessel diseaseHigh bleeding risk patients

VessRx Coronary Stent System

NMPA

VessRx Coronary Stent System

MicroPort CardioFlow Medtech Corporation

A next-generation drug-eluting coronary stent system featuring advanced polymer technology and thin strut design. Part of MicroPort's comprehensive cardiovascular intervention portfolio.

Advanced polymer technologyThin strut designGood deliverabilityExcellent vessel wall apposition

Applications:

De novo coronary lesionsStandard coronary interventionsLong lesionsComplex interventions

VessRx Plus Bioresorbable Stent

NMPA

VessRx Plus Bioresorbable Stent

MicroPort CardioFlow Medtech Corporation

A bioresorbable coronary stent system designed to provide temporary vessel support and then fully absorb into the body. Part of MicroPort's innovation pipeline.

Bioresorbable materialTemporary vessel supportFull absorption in 2-3 yearsNo permanent implant

Applications:

Young patients with de novo lesionsVessels 2.5-3.75mm diameterShort to moderate length lesionsPatients preferring temporary implant

MedStent Drug-Eluting Stent

NMPA

MedStent Drug-Eluting Stent

Shanghai Mead Medical Technology Co., Ltd.

A drug-eluting coronary stent with biocompatible polymer coating. Designed for reliable performance in standard coronary interventions with good long-term outcomes.

Biocompatible polymer coatingControlled drug releaseGood radial strengthMultiple size options

Applications:

Standard coronary interventionsDe novo lesionsBail-out stentingAcute coronary syndromes

MedStent Plus Thin-Strut Stent

NMPA

MedStent Plus Thin-Strut Stent

Shanghai Mead Medical Technology Co., Ltd.

Advanced thin-strut drug-eluting stent with enhanced biocompatibility. Designed for complex coronary interventions with improved deliverability.

Ultra-thin strut designEnhanced biocompatibilityImproved deliverabilityRapid endothelialization

Applications:

Complex coronary lesionsBifurcation stentingLong lesionsHigh-risk patients

NuoStent Drug-Eluting Stent

NMPA

NuoStent Drug-Eluting Stent

Shanghai Nuoer Medical Technology Co., Ltd.

A sirolimus-eluting coronary stent with biodegradable polymer coating. Designed for reliable drug delivery and excellent clinical outcomes.

Biodegradable polymer coatingSirolimus drug releaseGood vessel wall appositionThin strut design

Applications:

De novo coronary lesionsStandard coronary interventionsLong lesionsMulti-vessel disease

NuoStent Plus Advanced Stent

NMPA

NuoStent Plus Advanced Stent

Shanghai Nuoer Medical Technology Co., Ltd.

Advanced drug-eluting stent with enhanced polymer technology and ultra-thin strut design. Improved deliverability and rapid endothelialization.

Enhanced polymer technologyUltra-thin strut (60μm)Rapid endothelializationGood flexibility

Applications:

Complex coronary interventionsBifurcation lesionsSmall vessel diseaseHigh-risk patients

HeartStent Drug-Eluting Stent

NMPA

HeartStent Drug-Eluting Stent

Shanghai Xinwei Medical Technology Co., Ltd.

A drug-eluting coronary stent featuring biodegradable polymer coating. Designed for neurovascular and cardiovascular interventions with excellent deliverability.

Biodegradable polymer coatingDual neuro/cardi applicationGood deliverabilityThin strut design

Applications:

De novo coronary lesionsNeurovascular interventionsStandard coronary interventionsComplex lesions

HeartStent Plus Ultra-Thin Stent

NMPA

HeartStent Plus Ultra-Thin Stent

Shanghai Xinwei Medical Technology Co., Ltd.

Next-generation ultra-thin strut drug-eluting stent with enhanced biocompatibility and rapid endothelialization. Designed for complex coronary and neurovascular interventions.

Ultra-thin strut (55μm)Enhanced biocompatibilityRapid endothelializationGood flexibility

Applications:

Complex coronary interventionsNeurovascular proceduresBifurcation lesionsHigh-risk patients

AcoArt Drug-Coated Balloon

NMPA, CE

AcoArt Drug-Coated Balloon

Acotec Scientific Co., Ltd.

A drug-coated balloon (DCB) for coronary artery disease treatment. Features controlled paclitaxel release for in-stent restenosis and small vessel disease.

Drug-coated balloon technologyControlled paclitaxel releaseNo permanent implantExcellent for ISR treatment

Applications:

In-stent restenosisSmall vessel diseaseHigh bleeding risk patientsVessels not suitable for stenting

AcoArt Litu Drug-Coated Balloon

NMPA, CE

AcoArt Litu Drug-Coated Balloon

Acotec Scientific Co., Ltd.

Advanced drug-coated balloon with enhanced drug delivery and coating uniformity. Designed for improved clinical outcomes in coronary artery disease.

Enhanced drug deliveryUniform coating technologyGood deliverabilityRapid drug release

Applications:

In-stent restenosisDe novo small vessel lesionsHigh bleeding risk patientsLong lesions

E-Sent Drug-Eluting Stent

NMPA

E-Sent Drug-Eluting Stent

Beijing E-Sent Technology Co., Ltd.

A sirolimus-eluting coronary stent with biocompatible polymer coating. Designed for reliable performance in standard coronary interventions.

Biocompatible polymer coatingSirolimus drug releaseGood radial strengthMultiple size options

Applications:

Standard coronary interventionsDe novo lesionsBail-out stentingAcute coronary syndromes

E-Sent Plus Thin-Strut Stent

NMPA

E-Sent Plus Thin-Strut Stent

Beijing E-Sent Technology Co., Ltd.

Advanced thin-strut drug-eluting stent with enhanced biocompatibility and rapid endothelialization. Improved deliverability for complex interventions.

Ultra-thin strut designEnhanced biocompatibilityRapid endothelializationGood flexibility

Applications:

Complex coronary interventionsBifurcation lesionsLong lesionsHigh-risk patients

Meizhong Shuanghe Drug-Eluting Stent

NMPA

Meizhong Shuanghe Drug-Eluting Stent

Beijing Meizhong Shuanghe Medical Technology Co., Ltd.

A drug-eluting coronary stent with biodegradable polymer coating. One of the early domestic DES manufacturers in China with established clinical track record.

Biodegradable polymer coatingEstablished clinical track recordGood radial strengthMultiple size options

Applications:

Standard coronary interventionsDe novo lesionsLong lesionsMulti-vessel disease

Meizhong Shuanghe Plus Stent

NMPA

Meizhong Shuanghe Plus Stent

Beijing Meizhong Shuanghe Medical Technology Co., Ltd.

Next-generation drug-eluting stent with enhanced polymer technology and thin strut design. Improved deliverability and vessel healing.

Enhanced polymer technologyThin strut designImproved deliverabilityRapid endothelialization

Applications:

Complex coronary interventionsHigh-risk patientsLong lesionsDiabetic patients

Yuanda Drug-Eluting Stent

NMPA

Yuanda Drug-Eluting Stent

China Grand Enterprises Yuanda Pharmaceutical Co., Ltd.

A drug-eluting coronary stent with biocompatible polymer coating. Part of Yuanda's cardiovascular intervention product line.

Biocompatible polymer coatingControlled drug releaseGood radial strengthMultiple size options

Applications:

Standard coronary interventionsDe novo lesionsBail-out stentingAcute coronary syndromes

Yuanda Plus Thin-Strut Stent

NMPA

Yuanda Plus Thin-Strut Stent

China Grand Enterprises Yuanda Pharmaceutical Co., Ltd.

Advanced thin-strut drug-eluting stent with enhanced biocompatibility. Designed for complex coronary interventions with improved outcomes.

Ultra-thin strut designEnhanced biocompatibilityRapid endothelializationGood flexibility

Applications:

Complex coronary interventionsBifurcation lesionsLong lesionsHigh-risk patients

Kindly Drug-Eluting Stent

NMPA

Kindly Drug-Eluting Stent

Shanghai Kindly Medical Technology Co., Ltd.

A drug-eluting coronary stent with biodegradable polymer coating. Part of Kindly's comprehensive interventional product portfolio.

Biodegradable polymer coatingControlled drug releaseGood vessel wall appositionMultiple size options

Applications:

Standard coronary interventionsDe novo lesionsLong lesionsMulti-vessel disease

Kindly Plus Advanced Stent

NMPA

Kindly Plus Advanced Stent

Shanghai Kindly Medical Technology Co., Ltd.

Advanced drug-eluting stent with enhanced polymer technology and thin strut design. Improved deliverability and rapid endothelialization.

Enhanced polymer technologyThin strut designRapid endothelializationGood flexibility

Applications:

Complex coronary interventionsBifurcation lesionsHigh-risk patientsLong lesions

Aeromedical Drug-Eluting Stent

NMPA

Aeromedical Drug-Eluting Stent

Beijing Aeromedical Technology Co., Ltd.

A drug-eluting coronary stent featuring biocompatible polymer coating. Designed for reliable performance in various coronary lesion types.

Biocompatible polymer coatingControlled drug releaseGood radial strengthMultiple size options

Applications:

Standard coronary interventionsDe novo lesionsBail-out stentingAcute coronary syndromes

Aeromedical Plus Thin-Strut Stent

NMPA

Aeromedical Plus Thin-Strut Stent

Beijing Aeromedical Technology Co., Ltd.

Advanced thin-strut drug-eluting stent with enhanced biocompatibility and rapid endothelialization. Designed for complex coronary interventions.

Ultra-thin strut designEnhanced biocompatibilityRapid endothelializationGood flexibility

Applications:

Complex coronary interventionsBifurcation lesionsLong lesionsHigh-risk patients

HuiTai Drug-Eluting Stent

NMPA

HuiTai Drug-Eluting Stent

Shenzhen HuiTai Medical Technology Co., Ltd.

A drug-eluting coronary stent with biocompatible polymer coating. Part of HuiTai's comprehensive cardiovascular intervention product line.

Biocompatible polymer coatingControlled drug releaseGood deliverabilityMultiple size options

Applications:

Standard coronary interventionsDe novo lesionsLong lesionsMulti-vessel disease

HuiTai Plus Advanced Stent

NMPA

HuiTai Plus Advanced Stent

Shenzhen HuiTai Medical Technology Co., Ltd.

Advanced drug-eluting stent with enhanced polymer technology and thin strut design. Improved deliverability and vessel healing.

Enhanced polymer technologyThin strut designRapid endothelializationGood flexibility

Applications:

Complex coronary interventionsBifurcation lesionsHigh-risk patientsLong lesions

MicroPort Endovascular Coronary Stent

NMPA

MicroPort Endovascular Coronary Stent

MicroPort Endovascular Scientific Co., Ltd.

A drug-eluting coronary stent system from MicroPort's endovascular division. Features advanced polymer technology and thin strut design for optimal vessel support.

Advanced polymer technologyThin strut designGood deliverabilityExcellent vessel support

Applications:

De novo coronary lesionsStandard coronary interventionsLong lesionsComplex interventions

MicroPort Endovascular Plus Stent

NMPA

MicroPort Endovascular Plus Stent

MicroPort Endovascular Scientific Co., Ltd.

Next-generation drug-eluting stent with enhanced biocompatibility and rapid endothelialization. Part of MicroPort Endovascular's innovation pipeline.

Enhanced biocompatibilityRapid endothelializationUltra-thin strutGood flexibility

Applications:

Complex coronary interventionsBifurcation lesionsHigh-risk patientsLong lesions

More in this Category

Explore other Interventional Devices subcategories

Coronary Stent (Bare Metal)

Coronary Bioresorbable Stent

Coronary Balloon Catheter

Coronary Special Balloon

Coronary Shockwave Balloon

Intracranial Stent

Intracranial Thrombectomy Stent

Flow Diverter Stent

Intracranial Balloon Catheter

Proximal Arterial Stent

Distal Arterial Stent

Peripheral Venous Stent

Peripheral Balloon Catheter

Peripheral Special Balloon

Vascular Occlusion Balloon

Vascular Embolization Balloon

Artificial Blood Vessels

Embolization Coils

Liquid Embolic Agent

Aneurysm Occlusion Device

Cardiac Measurement Balloon

Mitral Valve Balloon Catheter

Pulmonary Artery Balloon Catheter

Pulmonary Valve Balloon Catheter

Aortic Valve Balloon Catheter

Guiding Catheter

Puncture Needle

Introducer Sheath

Tracheobronchial Stent

Esophageal Stent

Intestinal Stent

Pancreatic Duct Stent

Cholangiopancreatic Stent

Airway Balloon Catheter

Cardia Balloon Catheter

Esophageal Balloon Catheter

Intestinal Balloon Catheter

Cholangiopancreatic Balloon Catheter

Cholangiopancreatic Stone Retrieval Balloon

Urinary System Balloon Catheter

ENT Balloon Catheter

Non-Vascular Occlusion Balloon

Compression Balloon Catheter

Other Categories

Surgical Robotics

General Medical Supplies

Surgical Instruments

Orthopedic Devices

Diagnostic Equipment

Patient Monitoring

In Vitro Diagnostics (IVD)

Dental Equipment